An Evaluation of Health Personnel Exposed to Occupational Injuries in Terms of HBV, HCV, and HIV Infections
Journal Title: Viral Hepatitis Journal - Year 2020, Vol 26, Issue 3
Abstract
Objectives: This study aims to determine the rates, distribution and risk factors of needle-stick and sharps injuries that cause diseases spread through blood and body fluids, to discuss relevant precautions, and to monitor seroconversion conditions of viral hepatitis and human immunodeficiency virus (HIV) in injured health personnel in our hospital. Materials and Methods: The data recorded by the Infection Control Committee about health personnel who were exposed to blood or body fluids as a result of needle-stick and sharps injuries between January 2018 and May 2020 were analyzed retrospectively. The results were presented as percentages. Results: A total of 187 health workers were included in the study. The injuries were most common among nurses 48.66%. The most common instrument causing needle-stick and sharps injuries was needle tip 80.8%. In addition, 89.85% of them were vaccinated for hepatitis B. According to the serological status of infected sources, 8.02% were infected with hepatitis B, 10.16% with hepatitis C and 2.67% with HIV. No seroconversion was observed in the injured personnel. Conclusion: Although health workers are given regular training on occupational hazards during recruitment and employment, they still face risky injuries. Therefore, all health personnel should be informed to raise their awareness of blood-borne infections, undergo medical screening regularly, and have up-to-date vaccines.
Authors and Affiliations
Özlem Aydın, Pınar Ergen, Hülya Çaşkurlu
The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience
Objectives: Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir (PrOD) seems to be highly effective and safe in chronic haemodialysis (CHD) patients. We presented our experiences of treatment with PrOD in CHD patients. Material...
The Importance of Antiviral Prophylaxis against Hepatitis B Virus in Patients under Immunosuppressive Therapy
Objectives: Immunosuppressive (IS) therapies present a risk of reactivation in patients with previous or known hepatitis B virus (HBV) infection and may cause mortality and morbidity. Before starting these therapies, pat...
Age Specific Hepatitis B Surface Antigen (HBsAg) and Anti-HBs Seroprevalence among Patients Admitted to a State Hospital
Objectives: Chronic hepatitis B (CHB) infection affects 257 million people globally, Turkey is middle endemic region. According to public health data, about 2 million people in Turkey are considered to be positive for he...
Effect of Advanced Fibrosis Presence on Adherence to Hepatocellular Carcinoma Surveillance in Chronic Hepatitis C Patients with Sustained Virologic Response
Objectives: Although hepatocellular carcinoma (HCC) screening is accepted as standard care in patients with chronic hepatitis C (CHC) diagnosis, sustained viral response (SVR) has been obtained by treatment and it is not...
Non-hodgkin Lymphoma Developing After Discontinuation of Direct-acting Antiviral Treatment for Hepatitis C: A Case Report
Today, direct-acting antivirals (DAA) are the main treatment options for hepatitis C infection. However, whether malignancy risk is increased after DAA treatment is a matter of debate. Conflicting results have been repor...